In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from China.
In: Journal of Antimicrobial Chemotherapy (JAC), Jg. 75 (2020-07-01), Heft 7, S. 1850-1858
academicJournal
Zugriff:
Titel: |
In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from China.
|
---|---|
Autor/in / Beteiligte Person: | Wang, Xiaojuan ; Zhao, Chunjiang ; Wang, Qi ; Wang, Zhanwei ; Liang, Xinyue ; Zhang, Feifei ; Zhang, Yawei ; Meng, Han ; Chen, Hongbin ; Li, Shuguang ; Zhou, Chengcheng ; Li, Henan ; Wang, Hui |
Zeitschrift: | Journal of Antimicrobial Chemotherapy (JAC), Jg. 75 (2020-07-01), Heft 7, S. 1850-1858 |
Veröffentlichung: | 2020 |
Medientyp: | academicJournal |
ISSN: | 0305-7453 (print) |
DOI: | 10.1093/jac/dkaa053 |
Sonstiges: |
|